0001144204-18-052159.txt : 20181002 0001144204-18-052159.hdr.sgml : 20181002 20181002192033 ACCESSION NUMBER: 0001144204-18-052159 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180928 FILED AS OF DATE: 20181002 DATE AS OF CHANGE: 20181002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chi George CENTRAL INDEX KEY: 0001753434 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20713 FILM NUMBER: 181103209 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE, SUITE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000895051 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581959440 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-864-2600 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ENTREMED INC DATE OF NAME CHANGE: 19960415 4 1 tv504024_4.xml OWNERSHIP DOCUMENT X0306 4 2018-09-28 0 0000895051 CASI Pharmaceuticals, Inc. CASI 0001753434 Chi George CASI PHARMACEUTICALS, INC., MEDICAL CENTER DRIVE, SUITE 300 ROCKVILLE MD 20850 0 1 0 0 Chief Financial Officer Stock Options (Right to Buy) 4.67 2018-09-28 4 A 0 400000 0 A 2028-09-28 Common Stock 400000 400000 D The stock options vest as follows: 25% on each of the first, second, third and fourth anniversary of the date of grant. /s/ Cynthia W. Hu, attorney-in-fact for George Chi 2018-10-02